AbbVie Inc. Common Stock (ABBV) stock — price, news and analysis
AbbVie Inc. Common Stock (ABBV) trades on US markets (NASDAQ / NYSE). OneDayTrading is tracking 3 recent stories on ABBV — 3 bullish and 0 bearish — alongside its live price and interactive chart below.
Catalystsby D-day
FOMC = U.S. Fed official schedule · expiry = US options/futures (3rd Friday)
Latest ABBV news
AbbVie Skyrizi Wins Pediatric Psoriatic Disease Label, Extending Post-Humira Runway (ABBV)
Jun 27, 2026
AbbVie (ABBV) Eyes $10.9B Biotech Buyout to Add Eczema Drug, Pressuring Dupixent
Jun 21, 2026
US Tariff Probe Into Germany Drug Pricing: What It Means for PFE, MRK, LLY Pharma Stocks
Jun 19, 2026Related stocks
Tickers frequently mentioned alongside ABBV in recent news.
ABBV — frequently asked
What is the ABBV stock price today?
The live AbbVie Inc. Common Stock (ABBV) price and an interactive chart are shown at the top of this page, updated in real time during US market hours (9:30 AM – 4:00 PM ET) and at the last close otherwise.
Where is ABBV listed?
AbbVie Inc. Common Stock (ABBV) is a US-listed equity traded on the NASDAQ / NYSE. It belongs to the 바이오 sector.
Is the latest ABBV news bullish or bearish?
Of the 3 recent ABBV stories we track, 3 are bullish, 0 bearish and 0 neutral. See the news section below for details.
Prices are delayed outside US market hours and provided for information only — not investment advice. AbbVie Inc. Common Stock (ABBV) news is produced from public information.